Telix Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	141.87	440	84.3	79.07	16.02
Cash & Short-Term Investments	141.87	440	84.3	79.07	16.02
Cash Growth	-67.76%	421.98%	6.61%	393.44%	-73.35%
Accounts Receivable	129.2	86.93	44.04	26.75	0.53
Other Receivables	9.17	12.73	5.24	4.46	14.63
Receivables	138.37	99.65	49.28	31.21	15.16
Inventory	37.08	23.62	12.74	5.76	2.51
Prepaid Expenses	12.96	6.84	-	1.7	0.88
Other Current Assets	-	-	12.38	-	-
Total Current Assets	330.28	570.12	158.69	117.74	34.57
Property, Plant & Equipment	115.61	33.65	20.86	12.8	4.6
Long-Term Investments	3.68	3.77	-	-	-
Goodwill	198.99	66.59	-	3.75	2.98
Other Intangible Assets	393.84	191.27	75.05	36.34	37.54
Long-Term Deferred Tax Assets	59.35	28.92	13.99	2.7	-
Other Long-Term Assets	62.24	46.06	8.66	0.22	0.15
Total Assets	1,164	940.38	277.26	173.56	79.85
Accounts Payable	71.66	42.23	54.33	11.42	8.64
Accrued Expenses	52.63	47.94	9.53	25.23	8.48
Short-Term Debt	-	-	-	-	0.01
Current Portion of Long-Term Debt	13.11	11.76	0.66	-	-
Current Portion of Leases	5.55	1.55	0.41	0.44	0.45
Current Income Taxes Payable	30.74	30.09	13.11	4.98	-
Current Unearned Revenue	0.96	7.54	7.92	3.63	4.51
Other Current Liabilities	56.97	63.99	25.42	12.46	5.53
Total Current Liabilities	231.62	205.09	111.37	58.15	27.62
Long-Term Debt	391.91	341.81	5.95	2.25	-
Long-Term Leases	56.53	5.04	5.25	4.41	1.39
Long-Term Unearned Revenue	1.48	3.32	8.32	16.77	17.84
Pension & Post-Retirement Benefits	0.44	0.31	0.21	0.15	0.1
Long-Term Deferred Tax Liabilities	44.71	5.8	-	-	-
Other Long-Term Liabilities	21.9	26.08	43.51	37.45	31.33
Total Liabilities	748.61	587.44	174.61	119.18	78.28
Common Stock	479.96	414.01	315.18	252.14	124.22
Retained Earnings	-154.54	-152.91	-187.12	-185.42	-126.13
Comprehensive Income & Other	89.95	91.84	-25.41	-12.34	3.48
Shareholders' Equity	415.38	352.94	102.65	54.38	1.57
Total Liabilities & Equity	1,164	940.38	277.26	173.56	79.85
Total Debt	467.11	360.16	12.26	7.1	1.85
Net Cash (Debt)	-325.24	79.84	72.03	71.97	14.18
Net Cash Growth	-	10.84%	0.09%	407.61%	-75.74%
Net Cash Per Share	-0.96	0.23	0.22	0.23	0.05
Filing Date Shares Outstanding	338.78	329.55	323.96	316.71	308.2
Total Common Shares Outstanding	338.78	334.73	323.73	316.34	285.07
Working Capital	98.66	365.03	47.32	59.59	6.95
Book Value Per Share	1.23	1.05	0.32	0.17	0.01
Tangible Book Value	-177.45	95.08	27.59	14.29	-38.95
Tangible Book Value Per Share	-0.52	0.28	0.09	0.05	-0.14
Land	18.85	11.95	-	6.68	1.71
Machinery	28.84	6.45	-	1.16	1.34
Construction In Progress	12.44	9.46	-	-	-
Leasehold Improvements	4.28	2.05	-	1.05	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.